Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
Journal article
Domingo E. et al, (2024), Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Journal article
Challoner BR. et al, (2023), The Journal of pathology
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
Journal article
Frei AL. et al, (2023), The journal of pathology. Clinical research
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
Journal article
Brown M. et al, (2023), EMBO Molecular Medicine
More than just a hangover – alcohol and carcinogenesis in Lynch syndrome
Journal article
Church DN., (2023), Disease Models & Mechanisms, 16
Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
Journal article
Wiley MB. et al, (2023), Cancers, 15
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.
Journal article
Taylor CA. et al, (2022), Nat Med
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.
Journal article
Saunders MP. et al, (2022), ESMO open, 7
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
Journal article
RAINBO Research Consortium None., (2022), International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Journal article
Vermij L. et al, (2022), Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35, 1475 - 1483
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Journal article
Kleppe A. et al, (2022), The Lancet. Oncology, 23, 1221 - 1232
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape
Journal article
Glaire MA. et al, (2022), The Journal of Pathology, 257, 340 - 351
Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
Journal article
Palles C. et al, (2022), American journal of human genetics, 109, 953 - 960
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Journal article
Horeweg N. et al, (2022), Nature communications, 13
Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
Journal article
Reijns MAM. et al, (2022), Nature, 602, 623 - 631
Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies.
Journal article
Ryan NAJ. et al, (2021), Cancers, 13
Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer.
Journal article
Jiang D. et al, (2021), EBioMedicine, 71
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
Journal article
McAlpine JN. et al, (2021), Cancer, 127, 2409 - 2422
Promises and challenges of adoptive T-cell therapies for solid tumours
Journal article
Morotti M. et al, (2021), British Journal of Cancer, 124, 1759 - 1776
Correction to: The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
Journal article
Russell H. et al, (2021), Clinical epigenetics, 13